January 19, 2018 / 6:30 AM / 6 months ago

BRIEF-Roche Unit Chugai Says Gets Japanese Approval Of Tecentriq For Treatment Of Unresectable, Advanced Or Recurrent Non-Small Cell Lung Cancer

Roche Holding Ag:

* ROCHE UNIT CHUGAI SAYS GETS JAPANESE APPROVAL OF TECENTRIQ FOR TREATMENT OF UNRESECTABLE, ADVANCED OR RECURRENT NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below